1 / 23

Antibiotic associated diarrhoea

Antibiotic associated diarrhoea. Dr. Muhabat Raji. Images used in this lecture were obtained from various internet websites. Their use is for educational purposes only. Expectations. Describe the bacteriology and virulence characteristics of Clostridium difficile as a cause of AAD

nstrickland
Download Presentation

Antibiotic associated diarrhoea

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Antibiotic associated diarrhoea Dr. Muhabat Raji Images used in this lecture were obtained from various internet websites. Their use is for educational purposes only.

  2. Expectations..... • Describe • the bacteriology and virulence characteristics of Clostridium difficile as a cause of AAD • the risk factors and clinical presentation of AAD • Discuss the principle of management and risk of recurrence in AAD • laboratory approaches to the diagnosis of AAD

  3. Outline • Introduction • Bacteriology and virulence of C. difficile • Pathophysiology of AAD due to C. difficile • Risk factors for AAD • Laboratory approaches to the diagnosis of AAD • Principles of management and recurrence

  4. Introduction • An anaerobic, spore-producing, gram-positive rod that was first isolated and described in 1935 • It was difficult to isolate the bacterium hence the name “difficile” • It is the most common cause of AAD or nosocomial diarrhoea

  5. Introduction • It is implicated in • 20% to 30% of patients with antibiotic-associated diarrhea (AAD) • 50% to 75% of those with antibiotic-associated colitis(AAC) • more than 90% of those with antibiotic-associated pseudomembranous colitis (PMC) • CDI is an important hospital-acquired infection associated with an increase in length of hospital stay and cost

  6. Introduction • Spores can persist in the environment for a long time. • Colonization rate • 20-70% of healthy infants • 3% healthy adults (2-15%) • 20% of hospitalized patients

  7. Introduction • Pathogenic strains of C. difficile produce toxins • Toxin A (enterotoxin) • Toxin B (cytotoxin) • Binary toxin • A+/ B+ strains • A-/B+ strains

  8. Introduction • New strain identified • B1/NAP1/027 • associated with increase toxin production • resistant to quinolones

  9. Introduction: community acquired vs. hospital acquired discharge admission 3 months after discharge 48 hours 4 weeks 8 weeks CA HA CO-HA indeterminate CA modified from McDonald LC et al, ICHE 2007;28:140-45

  10. Clostridium difficile: risk factors

  11. Transmission www.cdc.gov/ncidod/dhqp/pdf/infDis/Cdiff_CCJM02_06.pdf

  12. Pathophysiology: Clostridium difficile http://www.scielo.org.co/scielo.php

  13. Pathophysiology:Clostridium difficile

  14. Clinical presentation • The following scenario may occur • asymptomatic carriage • symptomatic disease (during antibiotic treatment, a few days after/weeks after antibiotic treatment) • AAD, • AAC, • PMC, • toxic megacolon

  15. Clinical presentation • Diarrhoea (stools are usually mucoid, greenish and foul smelling) • toxic megacolon megacolon

  16. Clostridium difficile: Lab tests • gram positive spore forming anaerobic bacilli • toxigenic strains are pathogenic and can cause disease • positive culture does not always mean an infection • presence of toxin in stools confirms diagnosis of CDI C. difficile spores http://www.cdiff-support.co.uk/images/spores.jpg

  17. Other investigations.. • Endoscopy • Radiological investigation

  18. Clostridium difficile: Lab tests • Stool culture • sensitive • 2-3 days for growth • cannot distinguish between toxigenic and non toxigenic • cell cytotoxin test • specific for cytotoxin B • EIA • toxin A only • toxin A and B • NAAT • toxin gene

  19. Management • discontinue the offending antimicrobial • IV fluid resuscitation • start on oral metronidazole or vancomycin • IV metronidazole maybe given but IV vancomycin should not be given • surgery (medical non responders, perforated colon or megacolon)

  20. Management • Isolation/cohort nursing • barrier nursing • hand washing with soap and water • alcohol based hand sanitizers not effective against spores • room cleaning with 1:10 bleach solution • do not use anti-motility medication

  21. Recurrence • about 20% of patients • 50% (re-infection with a new strain) • 50% (relapse) • stool transplants (NGT or enema)

  22. Conclusion • C. difficile is responsible for most cases of antibiotic associated diarrhoea • risk factors include use of antibiotics and hospital admission • Infection control procedures particularly hand washing with soap and water is very important to prevent spread of organism in a HC facility.

  23. Thank you for your attention

More Related